Paragraph 1
This year has been
of bad news
of COVID-19. Now, there is good news. There is a
in the
against the virus. Scientists from drug companies in the USA and Germany have developed a
against COVID-19. It has a 90 per cent success
and no serious side
. The head of the USA's National Institute of Allergy and
Diseases said: "The
are really quite good, I mean
."
